Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials

• 1 February 2001
• journal article
• review article
• Published by Elsevier in Seminars in Oncology
• Vol. 28, 13-19
• https://doi.org/10.1016/s0093-7754(01)90188-5

Abstract

Keywords

• BREAST CANCER
• ANTIBODY
• TREATMENT
• ADJUVANT
• TRASTUZUMAB
• HER2/NEU
• RATIONALE
• FINDINGS THAT DEMONSTRATE